Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Ken Suzuki Likely to Come Back as JPWA Chief after 2 Years
May 25, 2021
-
BUSINESS Japan Ethical Drug Market Contracts 1% in Jan.-Mar.; Keytruda Top-Selling Drug for 8th Quarter Running: IQVIA
May 25, 2021
-
BUSINESS Janssen Seeks Japan Approval for COVID-19 Vaccine
May 24, 2021
-
REGULATORY MOF Panel’s Proposal Urges More Stringent Drug Cost Control, Revisiting of Semi-Automatic Listing
May 24, 2021
-
REGULATORY Biz Improvement Order Issued to 3 Codevelopers over Kobayashi Kako’s Fudged Data
May 24, 2021
-
REGULATORY PMDA Review Report: Flexible Discussions Needed for Eligibility of AstraZeneca Vaccine
May 24, 2021
-
ORGANIZATION JPMA Will Work towards Price Maintenance for On-Patent Medicines: New President
May 24, 2021
-
REGULATORY Japan Approves Moderna and AstraZeneca COVID-19 Vaccines
May 21, 2021
-
REGULATORY AstraZeneca, Moderna COVID-19 Vaccines in Line for Japan Approval on May 21
May 21, 2021
-
BUSINESS AbbVie Looks to Continue Double-Digit Annual Growth in New 5-Year Biz Plan
May 21, 2021
-
BUSINESS Janssen’s Darzquro, Chugai’s Polivy, JCR’s Izcargo Now Available in Japan
May 20, 2021
-
BUSINESS 5-Camp Battle Heating Up in HIF-PH Market; Evrenzo, Duvroq Neck-and-Neck for Top Spot
May 19, 2021
-
REGULATORY Pharma to Govt: Maintain Prices of Patented Drugs, It’s the Global Standard
May 18, 2021
-
REGULATORY AstraZeneca, Moderna COVID-19 Vaccines Up for Key Panel Review on May 20
May 17, 2021
-
BUSINESS Big 4 Wholesalers’ Operating Margin Sinks to 0.49% on COVID-19, Competition
May 17, 2021
-
BUSINESS 2 Ono Employees Admits Bribery Charges over Onoact Prescriptions
May 17, 2021
-
REGULATORY Japan, Pfizer Agree on 50 Million Extra Vaccine Doses by Sept-End
May 17, 2021
-
BUSINESS FY2020 Sales of 7 Major Japan Drug Makers Slip 2.7% on COVID-19, Price Woes: Tally
May 14, 2021
-
BUSINESS Ono Cuts Opdivo Guidance to 110 Billion Yen for FY2021
May 14, 2021
-
REGULATORY Pharma Groups Want Price Maintenance for Patented Meds, Payer Sees It “Natural” to Rectify Gap: Chuikyo
May 13, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…